Your browser doesn't support javascript.
loading
Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control.
Yasuda, Shigemitsu; Inoue, Kazuyuki; Iida, Shinichiro; Oikawa, Yoichi; Namba, Akira; Isshiki, Masashi; Inoue, Ikuo; Kamei, Yoshimasa; Shimada, Akira; Noda, Mitsuhiko.
Afiliação
  • Yasuda S; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan. Electronic address: syasuda@saitama-med.ac.jp.
  • Inoue K; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Iida S; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Oikawa Y; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Namba A; Department of Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan.
  • Isshiki M; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Inoue I; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Kamei Y; Department of Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan.
  • Shimada A; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
  • Noda M; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan; Department of Diabetes, Metabolism and Endocrinology, Ichikawa Hospital, International University of Health and Welfare, Chiba, Japan.
J Diabetes Complications ; 35(4): 107850, 2021 04.
Article em En | MEDLINE | ID: mdl-33483230
AIMS: To examine the effects of strict glycemic control on the birthweight of infants born to Japanese patients with early- or mid-to-late-detected gestational diabetes mellitus (ed- or md-GDM). METHODS: We retrospectively examined the characteristics of 101 patients with GDM who underwent guideline-based glycemic control. A 75-g oral glucose tolerance test was conducted to diagnose GDM at gestational weeks 11-15 (ed-GDM subgroup) and 24-28 (md-GDM subgroup). RESULTS: Infant birthweight was significantly lower in the ed-GDM subgroup (n = 25) than in the md-GDM subgroup (n = 76) (2688.3 ±â€¯470.4 g vs. 3052.4 ±â€¯383.1 g, p < 0.05), and the proportion of low-birthweight infants (<2500 g) was significantly higher in the ed-GDM subgroup than in the md-GDM subgroup (32.0% vs. 5.3%, p < 0.005). Fasting plasma glucose (FPG) levels during early treatment and before delivery were significantly lower in the ed-GDM subgroup than in the md-GDM subgroup (76.1 ±â€¯10.4 mg/dL vs. 85.5 ±â€¯9.6 mg/dL, p < 0.001; 80.5 ±â€¯10.4 mg/dL vs. 90.4 ±â€¯10.3 mg/dL, p < 0.0001). CONCLUSIONS: Patients with ed-GDM showed significantly lower FPG levels during treatment compared to those with md-GDM, presumably indicating an association with the delivery of low-birthweight infants.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Diabetes Complications Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Diabetes Complications Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article